115 filings
Page 2 of 6
8-K
vxymqzwfuq6u5v85bj
8 Jan 24
Entry into a Material Definitive Agreement
7:05am
424B7
qrasa2qi
16 Nov 23
Prospectus with selling stockholder info
4:16pm
8-K
muca7n4 t7
2 Nov 23
Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights
4:10pm
8-K
dlqsr qlxwupz
12 Oct 23
Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors
4:13pm
8-K
povi5ahv
8 Aug 23
Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights
4:14pm
8-K
76cwphr98 uua24d
31 May 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
jmk0pwywn yoo4
25 May 23
Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008
5:05pm
8-K
hstb019vk1vmgd31
4 May 23
Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights
4:10pm
ARS
okubfg
21 Apr 23
Annual report to shareholders
4:06pm
DEFA14A
krvxmc
21 Apr 23
Additional proxy soliciting materials
4:04pm
8-K
7iwi oc1nbya06
18 Apr 23
Regulation FD Disclosure
10:42am
S-8
a0pn3
23 Feb 23
Registration of securities for employees
4:47pm
8-K
7ei4x
23 Feb 23
Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
4:11pm
8-K
82lr3 xse6yi7l0it
9 Jan 23
JPM Presentation January 2023
7:01am